|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.276
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.238
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.221
|
Human Mouse |
|
|
regeneration
|
GO:0031099 |
4 |
0.221
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.204
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.198
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.194
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.187
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.174
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.152
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.150
|
Human Fly |
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.150
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.149
|
Human Mouse |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.149
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.145
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.139
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.134
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.132
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.131
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.131
|
Human |
|
|
cation transport
|
GO:0006812 |
331 |
0.129
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.125
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.124
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.123
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.122
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.116
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.116
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.109
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.108
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.107
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.107
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.105
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.103
|
Human |
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.102
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.102
|
Human Mouse |
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.097
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.096
|
Fly |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.095
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.094
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.093
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.092
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.092
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.090
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.089
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.089
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.088
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.086
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.086
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.084
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.084
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.084
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.083
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.082
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.081
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.081
|
|
|
|
regulation of potassium ion transmembrane transport
|
GO:1901379 |
20 |
0.081
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.080
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.079
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.077
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.076
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.074
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.074
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.073
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.073
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.073
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.073
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.072
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.072
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.072
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.071
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.070
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.069
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.069
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.069
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.069
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.069
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.069
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.068
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.068
|
Mouse Rat Fly |
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.068
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.067
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.067
|
|
|
|
regulation of potassium ion transmembrane transporter activity
|
GO:1901016 |
16 |
0.066
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.065
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.064
|
|
|
|
catagen
|
GO:0042637 |
3 |
0.064
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.064
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.063
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.063
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.061
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.061
|
Human Fly |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.060
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.060
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.060
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.060
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.059
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.059
|
|
|
|
growth
|
GO:0040007 |
202 |
0.059
|
Fly |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.059
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.058
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.057
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.057
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.056
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.055
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.055
|
Human |
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.055
|
|
|
|
system process
|
GO:0003008 |
349 |
0.055
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.055
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.054
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.054
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.054
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.053
|
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
71 |
0.053
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.053
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.053
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.052
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.052
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.052
|
Human |
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.052
|
Human |
|
|
nerve development
|
GO:0021675 |
4 |
0.052
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.051
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.051
|
Human |
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.050
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.049
|
Human |
|
|
cell fate determination
|
GO:0001709 |
3 |
0.049
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.048
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.048
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.047
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.047
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
35 |
0.047
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.047
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
26 |
0.047
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.047
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.047
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.047
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.045
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.045
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.044
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.044
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.044
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.044
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.043
|
Human |
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.043
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
40 |
0.042
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.042
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.042
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.042
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.042
|
Human |
|
|
regulation of catagen
|
GO:0051794 |
3 |
0.042
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.041
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.041
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.041
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.041
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.041
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.041
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.041
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.040
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.039
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.039
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.038
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.038
|
Human |
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.038
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.038
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.038
|
Human |
|
|
renal system development
|
GO:0072001 |
63 |
0.037
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.037
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.037
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.037
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.036
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
31 |
0.036
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.036
|
Fly |
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.036
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.036
|
Human |
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.036
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.036
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.035
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.035
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.035
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.035
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.035
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.035
|
Mouse |
|
|
cell growth
|
GO:0016049 |
160 |
0.035
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.035
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.035
|
Human |
|
|
membrane fusion
|
GO:0061025 |
43 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.034
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.034
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.034
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.034
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.034
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
46 |
0.034
|
Human |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.033
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.033
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.033
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.033
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.033
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.033
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.033
|
Human |
|
|
release of cytoplasmic sequestered nf kappab
|
GO:0008588 |
4 |
0.033
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.033
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.032
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
29 |
0.032
|
|
|
|
single organism membrane fusion
|
GO:0044801 |
37 |
0.032
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.032
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.032
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.032
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.032
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.032
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.031
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.031
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.031
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.031
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.031
|
|
|
|
axis elongation
|
GO:0003401 |
4 |
0.031
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.031
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.031
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.031
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.031
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.031
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.030
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.030
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.030
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.030
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.030
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.030
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.030
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.030
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.030
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.030
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.029
|
Human |
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.029
|
Human |
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.029
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.029
|
Human |
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.029
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.029
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.029
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.029
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.029
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.029
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.028
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.028
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.028
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.028
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
24 |
0.028
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.028
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.028
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.028
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.028
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.028
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.028
|
Human |
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.028
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.028
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.028
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.028
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.028
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.028
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
15 |
0.028
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.028
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.027
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.027
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
54 |
0.027
|
Human |
|
|
stem cell development
|
GO:0048864 |
69 |
0.027
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.027
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.027
|
Human |
|
|
cell aggregation
|
GO:0098743 |
1 |
0.027
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.027
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.027
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.027
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.027
|
Human |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.027
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.027
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.027
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.026
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.026
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
50 |
0.026
|
Human |
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.026
|
Human |
|
|
innate immune response
|
GO:0045087 |
178 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.026
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.026
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
24 |
0.026
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.026
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.026
|
|
|
|
cardiac atrium development
|
GO:0003230 |
10 |
0.025
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.025
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.025
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.025
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.025
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.025
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.025
|
Human |
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
20 |
0.025
|
|
|
|
fear response
|
GO:0042596 |
0 |
0.025
|
|
|
|
regulation of glial cell proliferation
|
GO:0060251 |
4 |
0.025
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.025
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.025
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.025
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.025
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.025
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.024
|
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.024
|
|
|
|
regulation of mitochondrial membrane potential
|
GO:0051881 |
23 |
0.024
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.024
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.024
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.024
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.024
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.024
|
|
|
|
memory
|
GO:0007613 |
3 |
0.024
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.024
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.024
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.024
|
|
|
|
head development
|
GO:0060322 |
108 |
0.024
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.023
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.023
|
Human |
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.023
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
48 |
0.023
|
Human |
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
52 |
0.023
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.023
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.023
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.023
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.023
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.023
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.023
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.023
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.023
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.023
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.022
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.022
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.022
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.022
|
|
|
|
cellular response to uv
|
GO:0034644 |
32 |
0.022
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.022
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.022
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.022
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.022
|
Human |
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.022
|
Human |
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.022
|
|
|
|
mitochondrial fusion
|
GO:0008053 |
13 |
0.022
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.022
|
|
|
|
behavioral defense response
|
GO:0002209 |
0 |
0.022
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.022
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.022
|
Human |
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.022
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.022
|
Human |
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.022
|
Human |
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.022
|
|
|
|
neuron death in response to oxidative stress
|
GO:0036475 |
9 |
0.022
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.022
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.022
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.022
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.022
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.022
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.022
|
Mouse |
|
|
cartilage development
|
GO:0051216 |
31 |
0.021
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.021
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
2 |
0.021
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.021
|
|
|
|
mitochondrial fission
|
GO:0000266 |
14 |
0.021
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.021
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.021
|
|
|
|
cilium organization
|
GO:0044782 |
68 |
0.021
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.021
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.021
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.021
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.021
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.021
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.021
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.021
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
7 |
0.021
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.021
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.021
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.020
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.020
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.020
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.020
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
26 |
0.020
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.020
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.020
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.020
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.020
|
Human |
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.020
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.020
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
119 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
21 |
0.020
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.020
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.020
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.020
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.019
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.019
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.019
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.019
|
|
|
|
response to unfolded protein
|
GO:0006986 |
24 |
0.019
|
|
|
|
neuron remodeling
|
GO:0016322 |
2 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.019
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.019
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.019
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.019
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.019
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.019
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.019
|
|
|
|
thymus development
|
GO:0048538 |
3 |
0.019
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.019
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.019
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.019
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.019
|
|
|
|
endoderm formation
|
GO:0001706 |
33 |
0.019
|
|
|
|
regulation of male gonad development
|
GO:2000018 |
4 |
0.019
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.019
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.019
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.019
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.019
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.019
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
2 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.018
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.018
|
|
|
|
calcium dependent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016339 |
2 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.018
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.018
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.018
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.018
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.018
|
Human |
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.018
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.018
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.018
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.018
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.018
|
Human |
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.018
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
59 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.018
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.018
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.018
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.018
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.018
|
Human |
|
|
circulatory system process
|
GO:0003013 |
113 |
0.018
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.017
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.017
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.017
|
Human |
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.017
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.017
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.017
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
90 |
0.017
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.017
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.017
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.017
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c
|
GO:0008635 |
2 |
0.017
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.017
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.017
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
19 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.017
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.017
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.017
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.016
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.016
|
|
|
|
negative regulation of mitochondrion organization
|
GO:0010823 |
22 |
0.016
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.016
|
|
